DS
ROIV icon

David Shaw’s Roivant Sciences ROIV Stock Holding History

David Shaw’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105M Buy
2,972,702
+1,579,954
+113% +$46.7M 0.05% 426
2026
Q1 		$38.6M Buy
1,392,748
+997,344
+252% +$25.6M 0.02% 778
2025
Q4 		$8.58M Sell
395,404
-152,655
-28% -$3.01M ﹤0.01% 1886
2025
Q3 		$8.29M Buy
548,059
+464,375
+555% +$5.75M ﹤0.01% 1825
2025
Q2 		$943K Buy
+83,684
New +$907K ﹤0.01% 3269
2023
Q1 		– Sell
-125,530
Closed -$1M – 4795
2022
Q4 		$1M Buy
+125,530
New +$698K ﹤0.01% 3452

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

David Shaw's ROIV Position: Q2 2026 in Review

David Shaw increased its Roivant Sciences (ROIV) stake by 113% in Q2 2026, buying an estimated $46.7M and bringing the position to 2,972,702 shares worth $105M. The position accounts for 0.05% of the portfolio, ranked #426.

David Shaw first reported a position in ROIV in Q4 2022 and has held it in 6 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • David Shaw held 2,972,702 shares of Roivant Sciences worth $105M as of Q2 2026.
  • David Shaw bought 1,579,954 Roivant Sciences shares in Q2 2026, an estimated $46.7M.
  • Roivant Sciences made up 0.05% of David Shaw's portfolio in Q2 2026, its #426 holding.
  • David Shaw first reported a position in Roivant Sciences in Q4 2022 and has held it in 6 quarters since.
  • 495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.